Lv1
58 积分 2024-04-13 加入
T-cell-engaging bispecific antibodies in cancer
12小时前
待确认
Exploration of efficacy and safety of combined therapy of basiliximab with ruxolitinib for grade 3-4 steroid-refractory acute graft-versus-host disease: a registered clinical trial (NCT05021276)
4个月前
已关闭
Finally, a Successful Randomized Trial for GVHD
8个月前
已完结
Risk and prognostic factors for acute GVHD based on NIH consensus criteria
8个月前
已完结
Hematopoietic stem cell transplantation activity in China 2022–2023. The proportions of peripheral blood for stem cell source continue to grow: a report from the Chinese Blood and Marrow Transplantation Registry Group
8个月前
已完结
皖公网安备34019202002308
